AstraZeneca
AZN
#51
Rank
NZ$506.58 B
Marketcap
NZ$326.64
Share price
-1.52%
Change (1 day)
5.40%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$12.47

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$12.96. In 2024 the company made an earnings per share (EPS) of NZ$8.26 an increase over its 2023 EPS that were of NZ$6.99.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$12.47
2024NZ$8.2618.23%
2023NZ$6.9981.13%
2022NZ$3.86631.03%
2021NZ$0.53-88.11%
2020NZ$4.44136.89%
2019NZ$1.87-39.41%
2018NZ$3.09-28.27%
2017NZ$4.31-14.37%
2016NZ$5.0424.11%
2015NZ$4.06127.55%
2014NZ$1.78-51.96%
2013NZ$3.71-58.95%
2012NZ$9.04-32.2%
2011NZ$13.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-6.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.55-26.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.29-90.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.92-62.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.21 333.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.60-72.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$4.29-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.23-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.24-59.59%๐Ÿ‡ฌ๐Ÿ‡ง UK